Related Experiment Video

Updated: May 23, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory

Mei-Yi Wu1, Junjiang Fu, Jianming Xu

  • 1Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC 20037, USA. bcmmxw@gwumc.edu

Cell Research
|March 21, 2012
PubMed

Insights

Steroid receptor coactivator 3 (SRC-3) promotes cancer by suppressing macrophage migration inhibitory factor (MIF), which blocks cell death. Inhibiting MIF enhances cancer treatment effectiveness and reduces tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Steroid receptor coactivator 3 (SRC-3/AIB1) is an oncogene linked to drug resistance and reduced disease-free survival in cancer.
  • Autophagy is a cell death pathway with tumor suppressor functions.

Purpose of the Study:

  • To identify novel target genes of SRC-3.
  • To investigate the role of macrophage migration inhibitory factor (MIF) in SRC-3-mediated cancer progression and drug resistance.

Main Methods:

  • Gene expression analysis to identify SRC-3 targets.
  • Cell-based assays to assess the role of MIF in autophagy and cell survival.
  • Xenograft mouse models to evaluate tumorigenesis and chemosensitivity.

Main Results:

  • Macrophage migration inhibitory factor (MIF) was identified as a novel target gene of SRC-3.
  • MIF was found to suppress autophagic cell death, promoting cancer cell survival.
  • Suppression of MIF induced autophagic cell death, enhanced chemosensitivity, and inhibited tumor growth in vivo.

Conclusions:

  • SRC-3 promotes chemoresistance and tumorigenicity by upregulating MIF, thereby suppressing autophagic cell death.
  • Targeting MIF represents a potential therapeutic strategy to overcome SRC-3-driven drug resistance and enhance cancer treatment outcomes.

More Related Videos

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...